NLS Pharmaceutics Ltd. - SHS (NLSP)

Historical Portfolio Holders from Q1 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SHS
Shares, excl. options Q2 2024
8.53M
Holdings value Q2 2024
$1.85M
Value change Q2 2024
+$80.3K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
9
Number of buys Q2 2024
5
Number of sells Q2 2024
-2
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 8.53M $1.85M +$80.3K $0.22 9
2024 Q1 8.16M $1.48M +$395K $0.18 7
2023 Q4 5.83M $3.44M -$323K $0.59 5
2023 Q3 6.29M $4.35M -$133K $0.70 7
2023 Q2 6.46M $7.11M +$95.1K $1.10 9
2023 Q1 6.37M $9.62M +$872K $1.51 7
2022 Q4 5.79M $7.47M +$7.37M $1.29 4
2022 Q3 115K $72K -$672K $0.63 4
2022 Q2 1.27M $743K +$679K $0.59 4
2022 Q1 71.8K $102K -$54.5K $1.42 5
2021 Q4 131K $145K -$45.4K $1.11 7
2021 Q3 135K $335K +$145K $2.49 5
2021 Q2 65.3K $205K +$204K $3.14 4
2021 Q1 70K $283K +$283K $4.03 3